Cannell Capital - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$59,628
+54.0%
12,3710.0%0.01%
+50.0%
Q4 2022$38,721
-3.2%
12,3710.0%0.01%
-11.1%
Q3 2022$40,000
+300.0%
12,371
+349.7%
0.01%
+350.0%
Q2 2022$10,0002,7510.00%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CM Management, LLC 90,000$4340.52%
Greenlight Capital 546,560$2,634,4190.14%
Wealth Alliance Advisory Group, LLC 12,502$60,2600.02%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$280,0420.02%
Cannell Capital 12,371$59,6280.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 60,000$289,2000.01%
NewEdge Advisors, LLC 10,500$54,0750.00%
Tower Research Capital LLC (TRC) 6,844$330.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 94,207$454,0770.00%
View complete list of GAIN THERAPEUTICS INC shareholders